Clinical, laboratory and genetic features of Erdheim-Chester disease patients: analysis of a retrospective cohort of two reference centers in Latin America (2022)
- Authors:
- USP affiliated authors: PEREIRA, JULIANA - FM ; ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.1080/16078454.2021.2011547
- Subjects: NEOPLASIAS ÓSSEAS; SINAIS E SINTOMAS; BIÓPSIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Hematology
- ISSN: 1024-5332
- Volume/Número/Paginação/Ano: v. 27, n. 1, p. 65-69, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
BRANDAO, Antonio Adolfo Guerra Soares et al. Clinical, laboratory and genetic features of Erdheim-Chester disease patients: analysis of a retrospective cohort of two reference centers in Latin America. Hematology, v. 27, n. 1, p. 65-69, 2022Tradução . . Disponível em: https://doi.org/10.1080/16078454.2021.2011547. Acesso em: 31 dez. 2025. -
APA
Brandao, A. A. G. S., Abdo, A. R. N., Lage, L. A. de P. C., Fatobene, G., Pereira, J., & Rocha, V. G. (2022). Clinical, laboratory and genetic features of Erdheim-Chester disease patients: analysis of a retrospective cohort of two reference centers in Latin America. Hematology, 27( 1), 65-69. doi:10.1080/16078454.2021.2011547 -
NLM
Brandao AAGS, Abdo ARN, Lage LA de PC, Fatobene G, Pereira J, Rocha VG. Clinical, laboratory and genetic features of Erdheim-Chester disease patients: analysis of a retrospective cohort of two reference centers in Latin America [Internet]. Hematology. 2022 ; 27( 1): 65-69.[citado 2025 dez. 31 ] Available from: https://doi.org/10.1080/16078454.2021.2011547 -
Vancouver
Brandao AAGS, Abdo ARN, Lage LA de PC, Fatobene G, Pereira J, Rocha VG. Clinical, laboratory and genetic features of Erdheim-Chester disease patients: analysis of a retrospective cohort of two reference centers in Latin America [Internet]. Hematology. 2022 ; 27( 1): 65-69.[citado 2025 dez. 31 ] Available from: https://doi.org/10.1080/16078454.2021.2011547 - Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center
- Less intensive regimens may still be suitable for the initial treatment of primary mediastinal B-Cell lymphoma in resource-limited settings
- Acquired hemophagocytic lymphohistiocytosis as initial manifestation of multiple myeloma A case report and literature review
- Absolute monocyte count is a predictor of overall survival and progression-free survival in nodal peripheral T cell lymphoma
- Outcomes of HIV-associated Burkitt Lymphoma in Brazil: High treatment toxicity and refractoriness rates - A multicenter cohort study
- Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): retrospective data from a Latin American cohort
- Expression of CysLTR1 and 2 in Maturating Lymphocytes of Hyperplasic Tonsils Compared to Peripheral Cells in Children
- Macrophage migration inhibitory factor and chemokine RANTES in young pediatric patients with congenital cardiac communications: relation to hemodynamic parameters and the presence of Down syndrome
- CD4+ lymphocytes in asymptomatic HTLV-1 carriers present cell cycle arrest in GO/G1 phase
- Time-to-treatment of diffuse large B-cell lymphoma in São Paulo
Informações sobre o DOI: 10.1080/16078454.2021.2011547 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
